Literature DB >> 12023358

AP2 adaptor complex-dependent internalization of CD5: differential regulation in T and B cells.

Xianghuai Lu1, Robert C Axtell, James F Collawn, Andrew Gibson, Louis B Justement, Chander Raman.   

Abstract

CD5 is a key regulator of Ag receptor-mediated activation, selection, and differentiation in both T and B cells. Accumulating evidence indicates that lymphocyte activation and selection are sensitive to variations in levels of CD5 on the cell surface. We now show that CD5 expression on the surface of B and T cells is regulated posttranslationally by direct interaction with the mu(2) subunit of the AP2 adaptor complex that links transmembrane proteins to clathrin-coated pits. CD5 is rapidly internalized from the cell surface in lymphoid cell lines, mature splenic T and B cells, and peritoneal CD5(+) B cells following monovalent or bivalent ligation of the receptor. We mapped the mu(2) subunit binding site on CD5 to Y(429) and determined that the integrity of this site was necessary for CD5 internalization. Cross-linking of the Ag receptor with intact Abs inhibited CD5 internalization in B cells, but had the opposite effect in T cells. However, if F(ab')(2) Abs were used to stimulate the Ag receptor in B cells, the effect on CD5 internalization was now similar to that observed in T cells, indicating that signals through the Ag receptor and FcR regulate CD5 endocytosis in B cells. This was confirmed using an FcgammaRIIB1-deficient B cell line. The ability to differentially alter posttranslational CD5 expression in T and B cells is likely to be key in regulation of Ag receptor signaling and generation of tolerance in T and B lymphocytes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12023358     DOI: 10.4049/jimmunol.168.11.5612

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

Review 1.  CD5, an important regulator of lymphocyte selection and immune tolerance.

Authors:  Chander Raman
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

Review 2.  Autoreactive B cells and epigenetics.

Authors:  Yves Renaudineau; Soizic Garaud; Christelle Le Dantec; Ruby Alonso-Ramirez; Capucine Daridon; Pierre Youinou
Journal:  Clin Rev Allergy Immunol       Date:  2010-08       Impact factor: 8.667

3.  Potentially autoreactive naturally occurring transitional T3 B lymphocytes exhibit a unique signaling profile.

Authors:  Ganna A Liubchenko; Holly C Appleberry; V Michael Holers; Nirmal K Banda; Van C Willis; Taras Lyubchenko
Journal:  J Autoimmun       Date:  2012-02-24       Impact factor: 7.094

4.  A T-cell-directed chimeric antigen receptor for the selective treatment of T-cell malignancies.

Authors:  Maksim Mamonkin; Rayne H Rouce; Haruko Tashiro; Malcolm K Brenner
Journal:  Blood       Date:  2015-06-08       Impact factor: 22.113

Review 5.  CAR T-cells for T-cell malignancies: challenges in distinguishing between therapeutic, normal, and neoplastic T-cells.

Authors:  Marion Alcantara; Melania Tesio; Carl H June; Roch Houot
Journal:  Leukemia       Date:  2018-10-12       Impact factor: 11.528

6.  The ap-2 clathrin adaptor mediates endocytosis of an inhibitory killer cell Ig-like receptor in human NK cells.

Authors:  Amanda K Purdy; Diana A Alvarez Arias; Jennifer Oshinsky; Ashley M James; Ilya Serebriiskii; Kerry S Campbell
Journal:  J Immunol       Date:  2014-09-19       Impact factor: 5.422

7.  CD5 signalosome coordinates antagonist TCR signals to control the generation of Treg cells induced by foreign antigens.

Authors:  Gaëtan Blaize; Hélène Daniels-Treffandier; Meryem Aloulou; Nelly Rouquié; Cui Yang; Marlène Marcellin; Mylène Gador; Mehdi Benamar; Mariette Ducatez; Ki-Duk Song; Odile Burlet-Schiltz; Abdelhadi Saoudi; Paul E Love; Nicolas Fazilleau; Anne Gonzalez de Peredo; Renaud Lesourne
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-20       Impact factor: 11.205

Review 8.  Tumor buster - where will the CAR-T cell therapy 'missile' go?

Authors:  Chunrun Qu; Hao Zhang; Hui Cao; Lanhua Tang; Haoyang Mo; Fangkun Liu; Liyang Zhang; Zhenjie Yi; Lifu Long; Luzhe Yan; Zeyu Wang; Nan Zhang; Peng Luo; Jian Zhang; Zaoqu Liu; Weijie Ye; Zhixiong Liu; Quan Cheng
Journal:  Mol Cancer       Date:  2022-10-19       Impact factor: 41.444

9.  Evaluation of two internalizing carcinoembryonic antigen reporter genes for molecular imaging.

Authors:  Bhaswati Barat; Vania E Kenanova; Tove Olafsen; Anna M Wu
Journal:  Mol Imaging Biol       Date:  2011-06       Impact factor: 3.488

10.  Reversible Transgene Expression Reduces Fratricide and Permits 4-1BB Costimulation of CAR T Cells Directed to T-cell Malignancies.

Authors:  Maksim Mamonkin; Malini Mukherjee; Madhuwanti Srinivasan; Sandhya Sharma; Diogo Gomes-Silva; Feiyan Mo; Giedre Krenciute; Jordan S Orange; Malcolm K Brenner
Journal:  Cancer Immunol Res       Date:  2017-10-27       Impact factor: 11.151

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.